Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at a test to predict who might benefit from chemotherapy for breast cancer (OPTIMA)

Overview

Cancer types:

Breast cancer

Status:

Closed

Phase:

Phase 3

Details

This trial is looking at testing tissue samples to try and find if you might benefit from having chemotherapy to treat your breast cancer.

Recruitment start: 16 January 2017

Recruitment end: 31 December 2024

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Rob Stein

Supported by

Experimental Cancer Medicine Centre (ECMC)

Independent Cancer Patients Voice

NIHR Clinical Research Network: Cancer

NIHR Health Technology Assessment (HTA) programme

NIHR University College London Hospitals Biomedical Research Centre

University College London (UCL)

Warwick Clinical Trials Unit

Other information

There is more information on the OPTIMA trial website(link is external).

Last reviewed: 02 Jan 2025

CRUK internal database number: 9754

Help and support